Metabolic-associated fatty liver disease, An Issue of Endocrinology and Metabolism Clinics of North America, 1st Edition
Author :
Edited by Joseph M. Pappachan, MD, FRCP and Sherouk Fouda, Dr.
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the vari
...view more
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.
Key Features
Contains 12 practice-oriented topics including obstructive sleep apnea and MAFLD; the interlink between MAFLD and polycystic ovary syndrome; pregnancy and MAFLD; MAFLD and gut microbiota; and more.
Provides in-depth clinical reviews of metabolic associated fatty liver disease, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Joseph M. Pappachan, MD, FRCP, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust and Faculty of Science, Manchester Metropolitan University, UK and Sherouk Fouda, Dr., School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia
Edited by Joseph M. Pappachan, MD, FRCP, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust and Faculty of Science, Manchester Metropolitan University, UK and Sherouk Fouda, Dr., School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia
Pathobiology of Metabolic-Associated Fatty Liver Disease Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence Lean Metabolic-Associated Fatty Liver Disease Lipid Disorders and Metabolic-Associated Fatty Liver Disease Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy Metabolic-Associated Fatty Liver Disease and the Gut Microbiota Metabolic-Associated Fatty Liver Disease and Sarcopenia A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic[1]Associated Fatty Liver Disease Pregnancy and Metabolic-Associated Fatty Liver Disease The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome Management of Metabolic-Associated Fatty Liver Disease
https://www.asia.elsevierhealth.com/metabolic-associated-fatty-liver-disease-an-issue-of-endocrinology-and-metabolism-clinics-of-north-america-9780443184079.html306671Metabolic-associated fatty liver disease, An Issue of Endocrinology and Metabolism Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780443184079_8.jpg89.24118.99USDInStock/Medicine/Endocrinology/Clinics/Medicine & Surgery/Endocrinology/Clinics/Medicine/Endocrinology/Japan Titles/Clinics5054606505466643351795255041525989252631604388725In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications. In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.00add-to-cart97804431840792023ProfessionalEdited by Joseph M. Pappachan, MD, FRCP and Sherouk Fouda, Dr.20231Book152w x 229h (6.00" x 9.00")Elsevier240Jul 27, 2023IN STOCKEdited by <STRONG>Joseph M. Pappachan</STRONG>, MD, FRCP, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust and Faculty of Science, Manchester Metropolitan University, UK and <STRONG>Sherouk Fouda</STRONG>, Dr., School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, AustraliaClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
